Literature DB >> 24739055

Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice.

Jing Liu1, Zhen-Jie Zhuang, Dong-Xue Bian, Xiao-Jie Ma, Yun-Hao Xun, Wen-Jun Yang, Yan Luo, Yin-Lan Liu, Ling Jia, Yan Wang, Ming-Li Zhu, De-Wei Ye, Gang Zhou, Guo-Qiang Lou, Jun-Ping Shi.   

Abstract

The aim of the present study was to investigate Toll-like receptor-4 (TLR4) signalling at different stages of non-alcoholic fatty liver disease (NAFLD) induced by a high-fat, high-fructose (HFHFr) diet in mice. Both TLR4 wild-type (WT) and mutant (TLR4(mut) ) mice were fed either standard chow (SC) or the HFHFr diet for different periods of time from 4 to 16 weeks. Pathological characteristics and function of the liver were assessed. Simple steatosis, steatohepatitis and hepatic fibrosis occurred sequentially in Week 4, 8 and 16 in WT mice fed with the HFHFr. Expression of TLR4, myeloid differentiation factor 88 (MyD88), interferon regulatory factor (IRF) 3 and IRF7 started to increase at Week 4, peaked at Week 8 and then declined to basal levels at Week 16. This pattern was consistent with changes in inflammation in the liver revealed by haematoxylin and eosin staining. However, lipid accumulation, inflammation and fibrosis in livers of TLR4(mut) mice fed the HFHFr diet were significantly alleviated. In addition, the expression of activin A in WT mice fed the HFHFr diet increased at Week 16. The data suggest that TLR4 signalling mediates non-alcoholic steatohepatitis before fibrosis and that activin A is subsequently involved in NAFLD.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  mice; non-alcoholic fatty liver disease; toll -like receptor 4

Mesh:

Substances:

Year:  2014        PMID: 24739055     DOI: 10.1111/1440-1681.12241

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  23 in total

Review 1.  Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Authors:  Irina A Kirpich; Luis S Marsano; Craig J McClain
Journal:  Clin Biochem       Date:  2015-07-04       Impact factor: 3.281

Review 2.  Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

Authors:  Qun Liu; Shousheng Liu; Lizhen Chen; Zhenzhen Zhao; Shuixian Du; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

Review 3.  Cirrhosis-associated immune dysfunction.

Authors:  Agustín Albillos; Rosa Martin-Mateos; Schalk Van der Merwe; Reiner Wiest; Rajiv Jalan; Melchor Álvarez-Mon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-26       Impact factor: 46.802

4.  MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice.

Authors:  Jun Hu; Hui Du; Yinglin Yuan; Peipei Guo; Junxia Yang; Xinru Yin; Jin Liu; Shengwang Wu; Jingyuan Wan; Xia Gong
Journal:  Mediators Inflamm       Date:  2022-06-20       Impact factor: 4.529

5.  Oral supplementations with L-glutamine or L-alanyl-L-glutamine do not change metabolic alterations induced by long-term high-fat diet in the B6.129F2/J mouse model of insulin resistance.

Authors:  Patricia Martins Bock; Mauricio Krause; Helena Trevisan Schroeder; Gabriela Fernandes Hahn; Hilton Kenji Takahashi; Cinthia Maria Schöler; Graziella Nicoletti; Luiz Domingos Zavarize Neto; Maria Inês Lavina Rodrigues; Maciel Alencar Bruxel; Paulo Ivo Homem de Bittencourt
Journal:  Mol Cell Biochem       Date:  2015-11-03       Impact factor: 3.396

6.  Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver.

Authors:  Cristian A Alvarez Rojas; Brendan R E Ansell; Ross S Hall; Robin B Gasser; Neil D Young; Aaron R Jex; Jean-Pierre Y Scheerlinck
Journal:  Parasit Vectors       Date:  2015-02-25       Impact factor: 3.876

7.  Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway.

Authors:  Tingting Ren; Chao Huang; Mingliang Cheng
Journal:  Oxid Med Cell Longev       Date:  2014-11-27       Impact factor: 6.543

Review 8.  From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.

Authors:  Peng Zhao; Alan R Saltiel
Journal:  J Biol Chem       Date:  2020-07-10       Impact factor: 5.157

9.  TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression.

Authors:  Ana C P Souza; Takayuki Tsuji; Irina N Baranova; Alexander V Bocharov; Kenneth J Wilkins; Jonathan M Street; Alejandro Alvarez-Prats; Xuzhen Hu; Thomas Eggerman; Peter S T Yuen; Robert A Star
Journal:  Physiol Rep       Date:  2015-09

10.  An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease.

Authors:  Hadi Emamat; Maryam Noori; Forough Foroughi; Marjan Rismanchi; Hassan Eini-Zinab; Azita Hekmatdoost
Journal:  Middle East J Dig Dis       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.